• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2020 October 9

Post Archive by Day

Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study.

In Dermatology
by ClinOwl
October 9, 2020

Dupilumab is an effective treatment for moderate to severe atopic dermatitis (AD) with limited safety data in clinical practice.To assess the 6-month risk of conjunctivitis and serious infections in patients …

EFFECTIVENESS OF DUTASTERIDE IN A LARGE SERIES OF PATIENTS WITH FRONTAL FIBROSING ALOPECIA IN REAL CLINICAL PRACTICE.

In Dermatology
by ClinOwl
October 9, 2020

Dutasteride has been proposed as an effective therapy for frontal fibrosing alopecia (FFA).To describe the therapeutic response to dutasteride and the most effective dosage in FFA compared to other therapeutic …

View Post

DKA Episode May Harm Cognitive Function in Children With T1D

In HealthDay News
by Healthday
October 9, 2020

Lower IQ and worse memory seen in children with newly diagnosed type 1 diabetes and single event

View Post

Reproductive Factors Linked to Cardiovascular Disease in Women

In HealthDay News
by Healthday
October 9, 2020

For composite CVD, twofold link seen for preeclampsia, stillbirth, preterm birth; risk lower with longer breastfeeding

View Post

Type of Anesthesia Not Linked to Dementia Risk in Older Adults

In HealthDay News
by Healthday
October 9, 2020

Dementia risk did not differ by general, regional anesthesia in seniors undergoing elective surgery

View Post

Symptoms of COVID-19 Poor Marker for SARS-CoV-2 Infection

In HealthDay News
by Healthday
October 9, 2020

Only 13.9 percent of individuals with positive test reported specific symptoms on the day of the test

View Post

For Substance Abusers, Odds of Opioid Use Up With Cannabis Use

In HealthDay News
by Healthday
October 9, 2020

For adults using nonmedical opioids, odds of opioid use are increased on days when cannabis is used

View Post

Exercise Intensity Seems Not to Impact Mortality Levels

In HealthDay News
by Healthday
October 9, 2020

Combined MICT, HIIT intervention group had no difference in mortality versus recommended guidelines

View Post

Specific Factors Tied to Unemployment With MS Diagnosis

In HealthDay News
by Healthday
October 9, 2020

Many of the factors related to maintenance of employment are alterable

View Post

Disparities in Insulin Pump Use Persist, 2005 to 2019

In HealthDay News
by Healthday
October 9, 2020

Use higher among White children with type 1 diabetes versus Black and Hispanic children

  • Page 1 of 2
  • 1
  • 2
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

October 2020
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep   Nov »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer